By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Immune System Diseases and Conditions - HIV/AIDS have been published. According to news reporting originating from New York City, New York, by NewsRx correspondents, research stated, “The HPTN 067/Alternative Dosing to Augment Pre-Exposure Prophylaxis Pill Taking (ADAPT) study evaluated daily and non-daily dosing schedules for oral pre-exposure prophylaxis (PrEP) to prevent HIV. A qualitative sub-study including focus groups and in-depth interviews was conducted among men who have sex with men participating in New York City to understand their experience with PrEP and study dosing schedules.”
Financial support for this research came from National Institute of Allergy and Infectious Diseases.
Our news editors obtained a quote from the research from Columbia University, “The 37 sub-study participants were 68% black, 11% white, and 8% Asian; 27% were of Hispanic/Latino ethnicity. Mean age was 34 years. Themes resulting from qualitative analysis include: PrEP is a significant advance for HIV prevention; non-daily dosing of PrEP is congruent with HIV risk; and pervasive stigma connected to HIV and risk behavior is a barrier to PrEP adherence, especially for non-daily dosing schedules.”
According to the news editors, the research concluded: “The findings underscore how PrEP intersects with other HIV prevention practices and highlight the need to understand and address multidimensional stigma related to PrEP use.”
For more information on this research see: Sex, PrEP, and Stigma: Experiences with HIV Pre-exposure Prophylaxis Among New York City MSM Participating in the HPTN 067/ADAPT Study. AIDS and Behavior , 2018;22(4):1139-1149. AIDS and Behavior can be contacted at: Springer, Plenum Publishers, 233 Spring St, New York, NY 10013, USA. (Springer - www.springer.com; AIDS and Behavior - http://www.springerlink.com/content/1090-7165/)
The news editors report that additional information may be obtained by contacting J. Franks, Columbia University, Harlem Prevent Center, ICAP, New York, NY 10027, United States. Additional authors for this research include Y. Hirsch-Moverman, A.S. Loquere, K.R. Amico, R.M. Grant, B.J. Dye, Y. Rivera, R. Gamboa and S.B. Mannheimer.
The direct object identifier (DOI) for that additional information is: https://doi.org/10.1007/s10461-017-1964-6. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2018, NewsRx LLC
CITATION: (2018-05-05), Findings in HIV/AIDS Reported from Columbia University (Sex, PrEP, and Stigma: Experiences with HIV Pre-exposure Prophylaxis Among New York City MSM Participating in the HPTN 067/ADAPT Study), Obesity, Fitness & Wellness Week, 1104, ISSN: 1532-4664, BUTTER® ID: 015583166
From the newsletter Obesity, Fitness & Wellness Week.
https://www.newsrx.com/Butter/#!Search:a=15583166
This is a NewsRx® article created by NewsRx® and posted by NewsRx®. As proof that we are NewsRx® posting NewsRx® content, we have added a link to this steemit page on our main corporate website. The link is at the bottom left under "site links" at https://www.newsrx.com/NewsRxCorp/.
We have been in business for more than 20 years and our full contact information is available on our main corporate website.
We only upvote our posts after at least one other user has upvoted the article to increase the curation awards of upvoters.
NewsRx® offers 195 weekly newsletters providing comprehensive information on all professional topics, ranging from health, pharma and life science to business, tech, energy, law, and finance. Our newsletters report only the most relevant and authoritative information from qualified sources.